Skip to main navigation Skip to search Skip to main content

The use of a series of ketamine infusions in two patients with treatment-resistant depression

  • Michael Messer
  • , Irina V. Haller
  • , Pamela Larson
  • , Julia Pattison-Crisostomo
  • , Charles E. Gessert

Research output: Contribution to journalArticlepeer-review

Abstract

Treatment-resistant depression often leads to increased morbidity and disability. The authors report the use of ketamine, a selective N-methyl-d-aspartate (NMDA) receptor antagonist, in two patients with treatment-resistant depression. Multiple ketamine treatments may provide an effective rapid antidepressant effect with prolonged benefit.

Original languageEnglish (US)
Pages (from-to)442-444
Number of pages3
JournalJournal of Neuropsychiatry and Clinical Neurosciences
Volume22
Issue number4
DOIs
StatePublished - Jan 1 2010

Fingerprint

Dive into the research topics of 'The use of a series of ketamine infusions in two patients with treatment-resistant depression'. Together they form a unique fingerprint.

Cite this